必利勁提前-台裕化學製藥廠股份有限公司相關藥物 | 合法藥品大搜索
CLICK HERE for updated COVID-19 information and a detailed description of proactive measures we are undertaking to protect our residents and staff.
As stated by the New York State Department of Health in its July 10, 2020 Health Advisory, limited visitation in nursing homes may begin as of July 15, 2020 if the Facility meets all criteria. The earliest possible date the Facility will meet the criteria is 04/06/21 to allow us to open for limited visitation. The Facility’s Visitation Plan, Visitation Fact Sheet, and Visitation Procedures are available on our website for your information.
All visitation will be by appointment only, which will be scheduled through our website. Click the image below:
Please click here for further information and continue to check our website for updates.
“台裕”解舒錠25 毫克(待芬尼朵) Gelso Tablets 25mg (Diphenidol ... | 合法藥品大搜索
“台裕”解舒錠25 毫克(待芬尼朵) · Gelso Tablets 25mg ... | 合法藥品大搜索
“台裕”解舒錠25 毫克(待芬尼朵)可能會有的適應症 ... | 合法藥品大搜索
台裕解舒錠的功效、正確用法及成分 | 合法藥品大搜索
必利勁提前 | 合法藥品大搜索
必利勁提前 | 合法藥品大搜索
必利勁提前-台裕化學製藥廠股份有限公司相關藥物 | 合法藥品大搜索
必利勁提前 | 合法藥品大搜索
藥品外觀資料集 | 合法藥品大搜索
【“台裕”解舒錠 25 毫克(待芬尼朵)】因內耳障礙所引起之眩暈(包括腦血管障礙及頭頸部外傷後遺症之眩暈),眼振、美尼攸氏症候群。
藥品名稱:“台裕”解舒錠25毫克(待芬尼朵)許可證字號:衛署藥製字第050013號許可證種類:製 劑適應症:因內耳障礙所引起之眩暈(...